StartsideBBN • SWX
Bellevue Group AG
14,50 CHF
15. jan., 06:10:02 GMT+1 · CHF · SWX · Ansvarsfraskrivelse
AksjeVerdipapir notert i CH
Forrige sluttkurs
14,75 CHF
Dagsintervall
14,50 CHF - 14,80 CHF
Årsintervall
11,05 CHF - 24,30 CHF
Markedsverdi
195,19 mill. CHF
Gjennomsnittlig volum
9,95k
P/E-tall
13,08
Utbytte
7,93 %
Hovedbørs
SWX
Markedsnyheter
Økonomi
Resultatregnskap
Omsetning
Nettoomsetning
(CHF)juni 2024Endring år til år
Omsetning
18,41 mill.−11,31 %
Driftskostnader
13,73 mill.−10,56 %
Nettoomsetning
3,72 mill.−7,22 %
Netto resultatmargin
20,184,61 %
Fortjeneste per aksje
EBITDA
Faktisk avgiftssats
17,26 %
Totale aktiva
Totale passiva
(CHF)juni 2024Endring år til år
Kontant / kortsiktige inv.
30,49 mill.100,63 %
Totale aktiva
138,75 mill.−4,69 %
Totale passiva
22,05 mill.−24,81 %
Total egenkapital
116,70 mill.
Utestående aksjer
13,20 mill.
P/B-forhold
1,67
Avkastning på aktiva
10,71 %
Avkastning på kapital
Netto kontantstrøm
(CHF)juni 2024Endring år til år
Nettoomsetning
3,72 mill.−7,22 %
Kontantstrøm fra drift
3,65 mill.137,31 %
Kontanter fra investering
Kontanter fra finansiering
−8,10 mill.45,85 %
Netto kontantstrøm
−4,17 mill.83,13 %
Fri kontantstrøm
Om
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021. Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
Administrerende direktør
Grunnlagt
1993
Nettsted
Ansatte
88
Søk
Slett søket
Lukk søkefunksjonen
Google-apper
Hovedmeny